supp.fit

Vitamin B12 and Folic Acid: study protocols

211 study groups took Vitamin B12 together with Folic Acid. These are the doses the studies gave. They are not a recommendation.

Vitamin B12: what the research found →

Dose per serving from research: Vitamin B12

211 study groups in 171 studies say how much Vitamin B12 participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 250 mcg to 500 mcg, 41% of 211 study groups.

Daily doseStudy groups
1 mcg or less
2
1 mcg to 2.5 mcg
13
2.5 mcg to 5 mcg
15
5 mcg to 10 mcg
18
10 mcg to 25 mcg
2
25 mcg to 50 mcg
9
50 mcg to 100 mcg
5
100 mcg to 250 mcg
2
250 mcg to 500 mcg
87
500 mcg to 1 mg
45
1 mg to 2.5 mg
5
over 2.5 mg
8

Dose per serving from research: Folic Acid

209 study groups in 169 studies say how much Folic Acid participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 500 mcg to 1 mg, 26% of 209 study groups.

Daily doseStudy groups
100 mcg or less
2
100 mcg to 250 mcg
13
250 mcg to 500 mcg
51
500 mcg to 1 mg
55
1 mg to 2.5 mg
32
2.5 mg to 5 mg
36
5 mg to 10 mg
5
10 mg to 25 mg
10
over 25 mg
5

Commonly used together

163 of 211 study groups took Vitamin B12 and Folic Acid with something else. Shown: what 3 or more different studies gave. The 10 most common of 21.

What was given together, not what works together.

Taken withStudy groups
Vitamin B6
124
Iron
23
Vitamin E
20
Riboflavin
18
Vitamin C
17
Vitamin D
16
Zinc
14
Vitamin A
12
Copper
10
Niacin
10

211 study groups

Study
Study of the effectiveness of additional reductions in cholesterol and homocysteine (SEARCH): characteristics of a randomized trial among 12064 myocardial infarction survivors
2007 · Homocysteine-lowering group · Myocardial infarction survivors
1 mg2 mg6 years—
B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial
2010 · B vitamins · Patients with recent stroke or transient ischaemic attack within the past 7 months
500 mcg2 mg1241 days4,089
Treatment with B vitamins and incidence of cancer in patients with previous stroke or transient ischemic attack: results of a randomized placebo-controlled trial
2012 · B vitamins · Patients with recent stroke or transient ischemic attack
500 mcg2 mg1241 days4,082
Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial
2012 · B-vitamins group · Adults with a stroke or transient ischaemic attack within the previous 7 months; men and women, age not restricted
500 mcg2 mg1241 days4,040
Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial
2008 · Active treatment · Women aged 40 years or older with a history of cardiovascular disease or at least three cardiovascular risk factors
1 mg2.5 mg2665 days2,721
Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study
2009 · folic acid/B6/B12 group · Women at high risk of cardiovascular disease, with preexisting cardiovascular disease or at least three coronary risk factors; women included in these AMD analyses had no AMD diagnosis at baseline.
1 mg2.5 mg2665 days2,607
Effect of homocysteine-lowering treatment with folic Acid and B vitamins on risk of type 2 diabetes in women: a randomized, controlled trial
2009 · Active treatment · Women aged 45 years or older at high risk for cardiovascular disease, without diabetes at baseline
1 mg2.5 mg2665 days2,132
Folic Acid, Vitamin B6, and Vitamin B12 in Combination and Age-Related Cataract in a Randomized Trial of Women
2016 · combination treatment group · Women with preexisting cardiovascular disease or at least three coronary risk factors; ages 40 and older
1 mg2.5 mg2665 days1,969
B vitamins to enhance treatment response to antidepressants in middle-aged and older adults: results from the B-VITAGE randomised, double-blind, placebo-controlled trial
2014 · vitamins · Community-dwelling adults aged 50 years or over with DSM-IV-TR major depression
500 mcg2 mg52 weeks77
Homocysteine lowering with folic acid and B vitamins in vascular disease
2006 · active-treatment group · Patients aged 55 years or older with vascular disease or diabetes
1 mg2.5 mg5 years—
Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial
2008 · combined folic acid/vitamin B6/vitamin B12 treatment · Women aged 40 years or older with a history of cardiovascular disease or at least three coronary risk factors
1 mg2.5 mg2666 days—
Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial
2009 · vitamin therapy group · Adults with known cardiovascular disease
1 mg2.5 mg5 years—
B-vitamins reduce the long-term risk of depression after stroke: The VITATOPS-DEP trial
2010 · B-vitamins · Stroke survivors; age and sex not specified
500 mcg2 mg383 days—
Effect of daily vitamin B-12 and folic acid supplementation on fracture incidence in elderly individuals with an elevated plasma homocysteine concentration: B-PROOF, a randomized controlled trial
2014 · vitamin B-12 plus folic acid group · Adults aged 65 years or older with elevated plasma homocysteine concentrations (12–50 μmol/L)
500 mcg400 mcg2 years—
Folic Acid and Vitamin B12 Supplementation and the Risk of Cancer: Long-term Follow-up of the B Vitamins for the Prevention of Osteoporotic Fractures (B-PROOF) Trial
2019 · B vitamins · B-PROOF trial participants; age and specific condition not stated in the abstract
500 mcg400 mcg3 years—
Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial
2008 · folic acid plus vitamin B12 plus vitamin B6 · Adults undergoing coronary angiography with coronary artery disease or aortic valve stenosis
400 mcg800 mcg165 weeks772
Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial
2008 · folic acid plus vitamin B12 · Adults undergoing coronary angiography with coronary artery disease or aortic valve stenosis
400 mcg800 mcg165 weeks772
Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial
2002 · homocysteine-lowering therapy · Patients with coronary artery disease after successful percutaneous coronary intervention; age and sex not specified
400 mcg1 mg26 weeks272
Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial
2005 · daily oral treatment with folate and mecobalamin · Adults aged 65 years or older with residual hemiplegia at least 1 year after a first ischemic stroke
1.5 mg5 mg2 years—
Effectiveness of homocysteine lowering vitamins in prevention of thrombotic tendency at high altitude area: A randomized field trial
2015 · intervention · Indian soldiers freshly inducted to a high-altitude area
1 mg5 mg2 years—
Effect of B vitamins and lowering homocysteine on cognitive impairment in patients with previous stroke or transient ischemic attack: a prespecified secondary analysis of a randomized, placebo-controlled trial and meta-analysis
2013 · B-vitamins · Patients with previous stroke or transient ischemic attack who were cognitively unimpaired at the cognitive assessment
500 mcg2 mg1241 days1,110
Folate and Vitamin B(12)-Related Biomarkers in Relation to Brain Volumes
2016 · B-vitamin group · Adults aged 65 years or older with mildly elevated plasma homocysteine (12–50 µmol/L)
500 mcg400 mcg2 years106
DHA status influences effects of B-vitamin supplementation on cognitive ageing: a post-hoc analysis of the B-proof trial
2022 · B-vitamin group · Men and women aged 65 years and older with elevated plasma homocysteine levels (12–50 µmol/L), cognitively healthy
500 mcg400 mcg2 years94
The association of betaine, homocysteine and related metabolites with cognitive function in Dutch elderly people
2007 · cobalamin plus folic acid group · Dutch elderly people; no diagnosed condition stated
1 mg400 mcg24 weeks—
A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease
2008 · B vitamin group · Women aged 65 years or older with cardiovascular disease or at least three coronary risk factors; female health professionals
1 mg2.5 mg2411 days—
Results of 2-year vitamin B treatment on cognitive performance: secondary data from an RCT
2014 · B-vitamin group · Adults aged 65 years and older with homocysteine levels of 12–50 µmol/L
500 mcg400 mcg2 years—
Effects of 2-year vitamin B12 and folic acid supplementation in hyperhomocysteinemic elderly on arterial stiffness and cardiovascular outcomes within the B-PROOF trial
2015 · B-vitamin supplementation · Adults aged at least 65 years with hyperhomocysteinemia (12–50 μmol/l)
500 mcg400 mcg2 years—
Effects of Two-Year Vitamin B(12) and Folic Acid Supplementation on Depressive Symptoms and Quality of Life in Older Adults with Elevated Homocysteine Concentrations: Additional Results from the B-PROOF Study, an RCT
2016 · intervention group · Adults aged 65 years or older from the general population with elevated homocysteine concentrations (12–50 µmol/L)
500 mcg400 mcg2 years—
B-vitamins and body composition: integrating observational and experimental evidence from the B-PROOF study
2020 · intervention group · Adults aged 65 years and older with elevated homocysteine levels (12–50 µmol/L)
500 mcg400 mcg2 years—
A randomized placebo-controlled trial of using B vitamins to prevent cognitive decline in older mild cognitive impairment patients
2020 · B vitamins supplementation · Adults aged 65 years or older with mild cognitive impairment and serum homocysteine ≥10.0 μmol/L
500 mcg400 mcg2 years—
B Vitamin Supplementation Slows Cognitive Decline in Mild Cognitive Impairment Patients with Frontal Lobe Atrophy
2022 · B vitamin supplementation · Mild cognitive impairment outpatients; age and sex not specified
500 mcg400 mcg2 years—
Effects of a nutritional supplement on the immune response and cytokine production in free-living Chilean elderly
2004 · special nutritional formula · Healthy adults aged 70 years or older with Mini Mental score ≥22
3.8 mcg400 mcg1 year30
Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomized trial in Nepal
2003 · Multiple micronutrients · Pregnant women in rural Nepal
2.6 mcg400 mcg——
Multivitamin supplementation of HIV-positive women during pregnancy reduces hypertension
2005 · Multivitamin plus vitamin A · HIV-positive pregnant Tanzanian women
50 mcg800 mcg——
Multivitamin supplementation of HIV-positive women during pregnancy reduces hypertension
2005 · Multivitamin without vitamin A · HIV-positive pregnant Tanzanian women
50 mcg800 mcg——
Aged garlic extract with supplement is associated with increase in brown adipose, decrease in white adipose tissue and predict lack of progression in coronary atherosclerosis
2013 · AGE-S · Subjects evaluated for coronary artery calcium; age, sex, and specific condition are not stated
100 mcg300 mcg1 year—
Oral folic acid and vitamin B-12 supplementation to prevent cognitive decline in community-dwelling older adults with depressive symptoms--the Beyond Ageing Project: a randomized controlled trial
2012 · daily oral folic acid + vitamin B-12 supplementation · Adults aged 60–74 with elevated psychological distress
100 mcg400 mcg2 years450
Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study
2009 · vitamin group · Adults aged 21 years or older with advanced chronic kidney disease or end-stage renal disease and high plasma homocysteine
2 mg40 mg1128 days339
High-dose B vitamin supplementation and progression of subclinical atherosclerosis: a randomized controlled trial
2009 · B-vitamin group · Men and postmenopausal women aged 40 years or older with fasting total homocysteine ≥8.5 μmol/L and no clinical signs or symptoms of cardiovascular disease
400 mcg5 mg1132 days254
High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial
2008 · high-dose supplement group · Adults over 50 with mild to moderate probable Alzheimer disease and normal vitamin B12 and folate levels
1 mg5 mg548 days240
Vitamins B12, B6, and folic acid for onset of depressive symptoms in older men: results from a 2-year placebo-controlled randomized trial
2008 · treatment with vitamins · Men aged 75 years and older, free of clinically significant depression at baseline
400 mcg2 mg2 years150
Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial
2012 · B-vitamin group · Adults aged 70 years or older with mild cognitive impairment
500 mcg800 mcg2 years133
Vitamin B12 and Folic Acid Improve Gross Motor and Problem-Solving Skills in Young North Indian Children: A Randomized Placebo-Controlled Trial
2015 · Vitamin B12 & Folic Acid · Children aged 6–30 months from low- to middle-socioeconomic-class families in New Delhi, India
1.8 mcg150 mcg26 weeks101
Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial
2010 · Active treatment group · Adults aged 70 years or older with mild cognitive impairment
500 mcg800 mcg2 years85
Improved vascular endothelial function after oral B vitamins: An effect mediated through reduced concentrations of free plasma homocysteine
2000 · Folic acid and vitamin B(12) · Men aged 39–67 years with coronary heart disease
1 mg5 mg8 weeks59
Additive effect of homocysteine- and cholesterol-lowering therapy on endothelium-dependent vasodilation in patients with cardiovascular disease
2012 · combined therapy · Patients with cardiovascular disease at high cardiovascular risk; age and sex not reported
400 mcg1 mg6 weeks36
Folate and vitamin B12 supplementation in patients with schizophrenia and low serum folate level: A 24-week randomized, double-blind, placebo-controlled study
2026 · folate group · Patients with schizophrenia and serum folate levels lower than 6 mg/L
500 mcg5 mg24 weeks36
Additive effect of homocysteine- and cholesterol-lowering therapy on endothelium-dependent vasodilation in patients with cardiovascular disease
2012 · group V · Patients with cardiovascular disease at high cardiovascular risk; age and sex not reported
400 mcg1 mg6 weeks18
Significant correlations of plasma homocysteine and serum methylmalonic acid with movement and cognitive performance in elderly subjects but no improvement from short-term vitamin therapy: a placebo-controlled randomized study
2005 · Vitamin therapy · Community-dwelling elderly adults, median age 76 years; both sexes; vitamin deficiencies were present in a subset
500 mcg800 mcg120 days—
Clinical trial: B vitamins improve health in patients with coeliac disease living on a gluten-free diet
2009 · B vitamin supplementation · Adults aged 45–64 years with longstanding coeliac disease, on a strict gluten-free diet for several years
500 mcg800 mcg26 weeks—
A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented people
2011 · supplement group · Older people with mild to moderate Alzheimer disease or vascular dementia
1 mg5 mg2 years—
Coronary blood flow in patients with stable coronary artery disease treated long term with folic acid and vitamin B12
2011 · Folic acid and vitamin B12, without vitamin B6 · Adults with stable coronary artery disease; mean age 57.8 years; sex not specified
400 mcg800 mcg2 years—
Coronary blood flow in patients with stable coronary artery disease treated long term with folic acid and vitamin B12
2011 · Folic acid and vitamin B12 plus vitamin B6 · Adults with stable coronary artery disease; mean age 57.8 years; sex not specified
400 mcg800 mcg2 years—
B-Vitamin Therapy for Kidney Transplant Recipients Lowers Homocysteine and Improves Selective Cognitive Outcomes in the Randomized FAVORIT Ancillary Cognitive Trial
2017 · treatment group (high-dose vitamin group) · Men and women aged 35–75 with stable kidney function for at least 6 months after kidney transplantation and elevated plasma homocysteine
1 mg5 mg2008 days—
The Vitamins in Psychosis Study: A Randomized, Double-Blind, Placebo-Controlled Trial of the Effects of Vitamins B(12), B(6), and Folic Acid on Symptoms and Neurocognition in First-Episode Psychosis
2019 · B-vitamin supplement group · Patients with first-episode psychosis; age and sex not specified
400 mcg5 mg12 weeks—
A pilot study with simvastatin and folic acid/vitamin B12 in preparation for the Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH)
2000 · combination group · Patients with primary hypercholesterolaemia; age and sex not reported
800 mcg2 mg6 weeks—
Associations of maternal nutrition during pregnancy and post-partum with maternal cognition and caregiving
2018 · MMN · Pregnant women enrolled at ≤20 weeks’ gestation in Malawi, followed through 6 months postpartum
5.2 mg400 mcg1 year239
Associations of maternal nutrition during pregnancy and post-partum with maternal cognition and caregiving
2018 · LNS · Pregnant women enrolled at ≤20 weeks’ gestation in Malawi, followed through 6 months postpartum
5.2 mg400 mcg1 year234
A smartphone application to improve adherence to vitamin and mineral supplementation after bariatric surgery
2022 · Intervention group · Adults aged over 18 to 60 years undergoing gastric bypass or sleeve gastrectomy
1 mg400 mcg1 year71
A smartphone application to improve adherence to vitamin and mineral supplementation after bariatric surgery
2022 · Control group · Adults aged over 18 to 60 years undergoing gastric bypass or sleeve gastrectomy
1 mg400 mcg1 year69
A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia
2010 · NF group, 3-month blinded trial · Community-dwelling adults aged 18–86 years, both sexes, without dementia or clinical memory difficulties
6 mcg400 mcg90 days59
Efficacy of multivitamin supplementation containing vitamins B6 and B12 and folic acid as adjunctive treatment with a cholinesterase inhibitor in Alzheimer's disease: a 26-week, randomized, double-blind, placebo-controlled study in Taiwanese patients
2007 · mecobalamin (B12) + multivitamin supplement · Taiwanese men and women aged over 50 with mild to moderate Alzheimer's disease and normal folic acid and vitamin B12 concentrations
500 mg1 mg26 weeks45
L-Arginine and B vitamins improve endothelial function in subjects with mild to moderate blood pressure elevation
2018 · Nutritional intervention group · Men and postmenopausal women aged 40–65 with slightly to moderately elevated blood pressure
2 mcg400 mcg26 weeks40
L-Arginine and B vitamins improve endothelial function in subjects with mild to moderate blood pressure elevation
2018 · Placebo group receiving open-label TAP in follow-up · Men and postmenopausal women aged 40–65 with slightly to moderately elevated blood pressure
2 mcg400 mcg13 weeks40
Effects of Low-Dose Dairy Protein Plus Micronutrient Supplementation during Resistance Exercise on Muscle Mass and Physical Performance in Older Adults: A Randomized, Controlled Trial
2018 · ExPM (resistance exercise plus low-dose dairy protein and micronutrient supplementation) · Adults aged 65–80 years, non-disabled and not exercising regularly
12 mcg200 mcg12 weeks40
A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia
2010 · Open-label NF group, separate 6-month trial · Community-dwelling adults, both sexes, without dementia or clinical memory difficulties
6 mcg400 mcg26 weeks38
Effects of ingesting a pre-workout dietary supplement with and without synephrine for 8 weeks on training adaptations in resistance-trained males
2017 · PWS · Apparently healthy, resistance-trained males; mean age about 21 years
70 mg50 mg8 weeks27
Effects of ingesting a pre-workout dietary supplement with and without synephrine for 8 weeks on training adaptations in resistance-trained males
2017 · PWS + S · Apparently healthy, resistance-trained males; mean age about 22 years
70 mg50 mg8 weeks26
Effects of acute ingestion of a pre-workout dietary supplement with and without p-synephrine on resting energy expenditure, cognitive function and exercise performance
2017 · PWS · Resistance-trained healthy adults; 20 men and 5 women, mean age 21.7 years
70 mg50 mg1 day25
Effects of acute ingestion of a pre-workout dietary supplement with and without p-synephrine on resting energy expenditure, cognitive function and exercise performance
2017 · PWS + S · Resistance-trained healthy adults; 20 men and 5 women, mean age 21.7 years
70 mg50 mg1 day25
Short-Term Effects of a Ready-to-Drink Pre-Workout Beverage on Exercise Performance and Recovery
2017 · RTD · Recreationally active men and women aged 18–40 years with at least six months of resistance-training experience
45 mcg325 mcg7 days25
Opicapone in Parkinson's Disease on Levodopa-Carbidopa Intestinal Gel Treatment: A Pilot, Randomized Study
2025 · addOPC group · Adults with Parkinson's disease receiving levodopa-carbidopa intestinal gel and experiencing nocturnal, morning, or afternoon akinesia
5 mcg400 mcg1 year11
Opicapone in Parkinson's Disease on Levodopa-Carbidopa Intestinal Gel Treatment: A Pilot, Randomized Study
2025 · nOPC group · Adults with Parkinson's disease receiving levodopa-carbidopa intestinal gel and experiencing nocturnal, morning, or afternoon akinesia
5 mcg400 mcg1 year11
A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia
2010 · NF group, 2-week blinded trial · Community-dwelling adults, both sexes, without dementia or clinical memory difficulties
6 mcg400 mcg2 weeks—
Improving neuropathy scores in type 2 diabetic patients using micronutrients supplementation
2011 · Group MVB · Patients with type 2 diabetes
10 mcg1 mg120 days—
Three-month B vitamin supplementation in pre-school children affects folate status and homocysteine, but not cognitive performance
2014 · B vitamin supplementation group · Healthy preschool children selected for low urinary folate-status ranking
1.2 mcg220 mcg90 days—
Low-dose B vitamins supplementation ameliorates cardiovascular risk: a double-blind randomized controlled trial in healthy Chinese elderly
2015 · treatment group · Healthy adults aged 60–74 years
10 mcg400 mcg1 year—
Folic acid and vitamin B12 supplementation in subjects with type 2 diabetes mellitus: A multi-arm randomized controlled clinical trial
2020 · Group C · Patients with type 2 diabetes mellitus on stable oral antidiabetic drugs
500 mcg5 mg8 weeks20
Lowering homocysteine with B vitamins has no effect on blood pressure in older adults
2007 · Vitamins group · Healthy adults aged 65 years or older with homocysteine concentrations of at least 13 micromol/L
500 mcg1 mg2 years—
A 2-Year Randomized Controlled Trial With Low-Dose B-Vitamin Supplementation Shows Benefits on Bone Mineral Density in Adults With Lower B12 Status
2022 · B-vitamin treatment · Community-dwelling adults aged 50 years or older; men and women; no specific diagnosed condition, and not currently taking B-vitamin supplements at screening
10 mcg200 mcg2 years103
Aged garlic extract supplemented with B vitamins, folic acid and L-arginine retards the progression of subclinical atherosclerosis: a randomized clinical trial
2009 · AGE+S · Intermediate-risk adults, mean age 60 ± 9 years; 79% male
100 mcg300 mcg1 year—
Folic acid and vitamin B(12) supplementation lowers plasma homocysteine but has no effect on serum bone turnover markers in elderly women: a randomized, double-blind, placebo-controlled trial
2013 · vitamin group · Women aged 65–93 years with homocysteine levels greater than 10 μmol/L
1 mg800 mcg120 days17
Effect of Combined Treatment With Folic Acid, Vitamin B(6), and Vitamin B(12) on Plasma Biomarkers of Inflammation and Endothelial Dysfunction in Women
2018 · Folic Acid/B6/B12 · Adult women at increased cardiovascular risk, with pre-existing cardiovascular disease or at least three coronary risk factors
1 mg2.5 mg2665 days150
A pilot study with simvastatin and folic acid/vitamin B12 in preparation for the Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH)
2000 · vitamins alone group · Patients with primary hypercholesterolaemia; age and sex not reported
800 mcg2 mg6 weeks—
Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized substudy of the VITATOPS trial
2005 · vitamin therapy · Patients with recent transient ischemic attack or stroke; age and sex not reported
500 mcg2 mg26 weeks—
Sustained homocysteine-lowering effect over time of folic acid-based multivitamin therapy in stroke patients despite increasing folate status in the population
2005 · active VITATOPS medication · Patients with stroke or transient ischemic attack
500 mcg2 mg26 weeks—
Decrease of carotid intima-media thickness in patients at risk to cerebral ischemia after supplementation with folic acid, Vitamins B6 and B12
2005 · treatment group · Adults aged 60 ± 8 years with carotid intima-media thickness ≥1 mm and at risk of cerebral ischemia
500 mcg2.5 mg1 year—
Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients with vascular disease
2005 · folic acid plus vitamin B-12 · Adults aged 65 years or older with ischemic vascular disease
500 mcg2.5 mg1 year—
Effect of long-term homocysteine reduction with B vitamins on arterial wall inflammation assessed by fluorodeoxyglucose positron emission tomography: a randomised double-blind, placebo-controlled trial
2009 · B-vitamin therapy · Adults with a history of ischemic stroke
500 mcg2 mg1461 days—
Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial
2010 · B-vitamin group · People with type 1 or type 2 diabetes and a clinical diagnosis of diabetic nephropathy
1 mg2.5 mg3 years—
Vitamin B-12 supplementation during pregnancy and early lactation increases maternal, breast milk, and infant measures of vitamin B-12 status
2014 · Vitamin B-12 group · Pregnant women in Bangalore, India, enrolled before 14 weeks of gestation; followed through early lactation
50 mcg——183
Bread cofortified with folic acid and vitamin B-12 improves the folate and vitamin B-12 status of healthy older people: a randomized controlled trial
2008 · bread fortified with folic acid and vitamin B-12 · Men and women aged 50–75 years described as healthy older people
9.6 mcg138 mcg12 weeks72
Folic acid causes higher prevalence of detectable unmetabolized folic acid in serum than B-complex: a randomized trial
2016 · B-complex · Elderly people
10 mcg400 mcg23 days27
Distribution of plasma folate forms in hemodialysis patients receiving high daily doses of L-folinic or folic acid
2002 · Folic acid group · Adults with chronic stable hemodialysis and hyperhomocysteinemia
1 mg15 mg12 weeks24
Holo-transcobalamin is an early marker of changes in cobalamin homeostasis. A randomized placebo-controlled study
2002 · Vitamin B(12), folic acid, and vitamin B(6) · Patients aged 38–80 years undergoing coronary angiography
400 mcg800 mcg12 weeks—
Holo-transcobalamin is an early marker of changes in cobalamin homeostasis. A randomized placebo-controlled study
2002 · Vitamin B(12) and folic acid · Patients aged 38–80 years undergoing coronary angiography
400 mcg800 mcg12 weeks—
Plasma vitamin B6 vitamers before and after oral vitamin B6 treatment: a randomized placebo-controlled study
2003 · Group A · Patients aged 38–80 years undergoing coronary angiography
400 mcg800 mcg12 weeks—
A randomised double-blind study comparing sodium feredetate with ferrous fumarate in anaemia in pregnancy
2007 · Group A · Pregnant women at 12–26 weeks’ gestation with iron-deficiency anaemia
30 mcg3 mg75 days—
A randomised double-blind study comparing sodium feredetate with ferrous fumarate in anaemia in pregnancy
2007 · Group B · Pregnant women at 12–26 weeks’ gestation with iron-deficiency anaemia
30 mcg3 mg75 days—
A randomised double-blind study comparing sodium feredetate with ferrous fumarate in anaemia in pregnancy
2007 · Group C · Pregnant women at 12–26 weeks’ gestation with iron-deficiency anaemia
30 mcg3 mg75 days—
Vitamin B12 supplementation during pregnancy and postpartum improves B12 status of both mothers and infants but vaccine response in mothers only: a randomized clinical trial in Bangladesh
2016 · B12 supplementation · Bangladeshi pregnant women aged 18–35 years, 11–14 weeks pregnant, with hemoglobin <110 g/L
250 mcg400 mcg——
Parenteral vs Oral Vitamin B12 in Children With Nutritional Macrocytic Anemia: A Randomized Controlled Trial
2022 · Group B (oral vitamin B12) · Children aged 2 months–18 years with nutritional macrocytic-megaloblastic anemia
1.5 mg—90 days—
One year B-vitamins increases serum and whole blood folate forms and lowers plasma homocysteine in older Germans
2015 · B-vitamin supplementation · Older German adults, mean age 67 years
500 mcg500 mcg1 year—
Maternal B-vitamin and vitamin D status before, during, and after pregnancy and the influence of supplementation preconception and during pregnancy: Prespecified secondary analysis of the NiPPeR double-blind randomized controlled trial
2023 · intervention · Women planning pregnancy; generally healthy, recruited before conception
5.2 mcg400 mcg—870
Antenatal Multiple Micronutrient Supplementation Compared to Iron-Folic Acid Affects Micronutrient Status but Does Not Eliminate Deficiencies in a Randomized Controlled Trial Among Pregnant Women of Rural Bangladesh
2019 · MM · Pregnant women aged 12–45 years in rural Bangladesh
2.6 mcg600 mcg165 days749
Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease
2015 · Active group (RCT1, RCT2 and RCT3) · Men and women aged 50 years or older with mild or mild-to-moderate Alzheimer's disease; RCT3 participants were on stable approved Alzheimer's medication, while RCT1 and RCT2 participants were drug-free for Alzheimer's medication.
3 mcg400 mcg24 weeks501
Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease
2015 · Active product during open-label extension (OLE) · Men and women aged 50 years or older with mild Alzheimer's disease who completed RCT2.
3 mcg400 mcg24 weeks201
Daily Folic Acid and/or Vitamin B12 Supplementation Between 6 and 30 Months of Age and Cardiometabolic Risk Markers After 6-7 Years: A Follow-Up of a Randomized Controlled Trial
2023 · Vitamin B12 and folic acid · Children aged 6–30 months at enrollment
1.8 mcg150 mcg180 days184
Newborn micronutrient status biomarkers in a cluster-randomized trial of antenatal multiple micronutrient compared with iron folic acid supplementation in rural Bangladesh
2020 · MM · Pregnant women in rural Bangladesh; age range not specified; no disease condition specified
2.6 mcg600 mcg—176
Daily supplementation of a multiple micronutrient powder improves folate but not thiamine, riboflavin, or vitamin B(12) status among young Laotian children: a randomized controlled trial
2022 · micronutrient powder group (MNP) · Children aged 6–23 months in rural Lao PDR; no disease-based selection, with high prevalence of undernutrition and micronutrient deficiencies
0.9 mcg150 mcg36 weeks130
Lowering plasma homocysteine concentrations of older men and women with folate, vitamin B-12, and vitamin B-6 does not affect the proportion of (n-3) long chain polyunsaturated fatty acids in plasma phosphatidylcholine
2008 · vitamin group · Men and women aged 65 years or older with plasma homocysteine concentrations of at least 13 micromol/L
500 mcg1 mg2 years127
Influence of folic acid and vitamin B12 supplementation on arsenic methylation: A double-blinded, placebo-controlled trial in Bangladeshi children
2024 · FA + B12 supplementation group · Children aged 8–11 years in Bangladesh exposed to drinking-water arsenic above 50 μg/L
5 mcg400 mcg12 weeks118
Multiple micronutrient supplementation improves vitamin B₁₂ and folate concentrations of HIV infected children in Uganda: a randomized controlled trial
2011 · Multiple micronutrient supplementation (MMS) · HIV-infected children aged 1–5 years
2.4 mcg40 mcg26 weeks104
Paraoxonase 1, B Vitamins Supplementation, and Mild Cognitive Impairment
2021 · B-vitamin group · Men and women, mean age 77.6 years, with mild cognitive impairment
500 mcg800 mcg2 years95
Brain atrophy in cognitively impaired elderly: the importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial
2015 · high-dose B vitamin supplementation · Adults aged 70 years or older with mild cognitive impairment
500 mcg800 mcg2 years85
Vitamin B12 decreases, but does not normalize, homocysteine and methylmalonic acid in end-stage renal disease: a link with glycine metabolism and possible explanation of hyperhomocysteinemia in end-stage renal disease
2003 · Daily multivitamin therapy with added vitamin B12 · Adults with end-stage renal disease receiving hemodialysis and with hyperhomocysteinemia
1 mg1 mg4 weeks81
Hyperhomocysteinemia in Japanese patients with convalescent stage ischemic stroke: effect of combined therapy with folic acid and mecobalamine
2002 · combined vitamin B(12) and folic acid group · Japanese patients with ischemic stroke in the convalescent stage
1.5 mg5 mg8 weeks64
Weekly iron as a safe alternative to daily supplementation for nonanemic pregnant women
2006 · Daily supplementation (DS) · Pregnant women with singleton pregnancies, at gestational week 20, with hemoglobin >115 g/L; nonanemic
1 mcg200 mcg16 weeks56
Homocysteine thiolactone contributes to the prognostic value of fibrin clot structure/function in coronary artery disease
2022 · Folic acid + vitamins B12, B6 · Adults with suspected coronary artery disease undergoing angiography for stable angina; mean age 61.2 years, 71.5% male
400 mcg800 mcg1387 days52
Homocysteine thiolactone contributes to the prognostic value of fibrin clot structure/function in coronary artery disease
2022 · Folic acid + vitamin B12 · Adults with suspected coronary artery disease undergoing angiography for stable angina; mean age 61.2 years, 71.5% male
400 mcg800 mcg1387 days52
[Impact of adding folic acid, vitamin B(12) and probucol to standard antihypertensive medication on plasma homocysteine and asymmetric dimethylarginine levels of essential hypertension patients]
2012 · group 2 · Patients with essential hypertension; age and sex not reported
1 mg5 mg12 weeks40
[Impact of adding folic acid, vitamin B(12) and probucol to standard antihypertensive medication on plasma homocysteine and asymmetric dimethylarginine levels of essential hypertension patients]
2012 · group 3 · Patients with essential hypertension; age and sex not reported
1 mg5 mg12 weeks40
[Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial]
2005 · Supraphysiological daily-dose regimen · Adults with stable maintenance hemodialysis (mean age 68 years; 48% male)
1 mg15 mg1 year33
Folate, vitamin B12, homocysteine status and DNA damage in young Australian adults
1998 · supplemented group · Young Australian adults aged 18–32 years; males and females; not folate deficient, with 4.4% vitamin B12 deficient
7 mcg700 mcg26 weeks31
A Randomized Pilot Trial to Evaluate the Bioavailability of Natural versus Synthetic Vitamin B Complexes in Healthy Humans and Their Effects on Homocysteine, Oxidative Stress, and Antioxidant Levels
2019 · Natural vitamin B complex (group N) · Healthy adults; age range and sex not specified
8.85 mcg690 mcg6 weeks30
A Randomized Pilot Trial to Evaluate the Bioavailability of Natural versus Synthetic Vitamin B Complexes in Healthy Humans and Their Effects on Homocysteine, Oxidative Stress, and Antioxidant Levels
2019 · Synthetic vitamin B complex (group S) · Healthy adults; age range and sex not specified
8.85 mcg690 mcg6 weeks30
Plasma homocysteine and markers for oxidative stress and inflammation in patients with coronary artery disease--a prospective randomized study of vitamin supplementation
2005 · open therapy with vitamins · Adults with ischemic heart disease and plasma homocysteine at least 15.0 micromol/L
1 mg5 mg90 days29
Preliminary results of the effect of treatment of hyperhomocysteinemia and its relationship with inflammation, coagulation status, and endothelial function after renal transplantation
2005 · Hyperhomocysteinemia patients treated with folic acid and vitamin B12 · Renal transplant recipients with hyperhomocysteinemia
500 mg10 mg90 days29
The impact of folate status and folic acid supplementation on the micronucleus frequency in human erythrocytes
2006 · folic acid, vitamin B12 and vitamin B6 supplementation group · Both-sex participants without folate deficiency; age not reported
20 mcg800 mcg7 days29
Vitamin supplementation reduces the progression of atherosclerosis in hyperhomocysteinemic renal-transplant recipients
2003 · group A · Adults with hyperhomocysteinemia who were stable renal-transplant recipients
400 mcg5 mg26 weeks28
[Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial]
2005 · Daily renal multivitamin regimen · Adults with stable maintenance hemodialysis (mean age 68 years; 48% male)
400 mcg5 mg1 year27
Controlled comparison of L-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients
2000 · FA group · Adults with chronic, stable hyperhomocysteinemia receiving hemodialysis
1 mg15 mg12 weeks25
Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients
2001 · Folic acid group · Adults with chronic, stable hyperhomocysteinemia receiving maintenance hemodialysis
1 mg15 mg12 weeks25
Rapid communication: L-folinic acid versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients
2001 · Folic acid group · Adults with chronic, stable hyperhomocysteinemia receiving hemodialysis
1 mg15 mg12 weeks24
Antioxidant supplementation with or without B-group vitamins after acute ischemic stroke: a randomized controlled trial
2006 · B-group vitamins · Acute ischemic stroke patients treated within 12 hours of symptom onset
400 mcg5 mg2 weeks24
Antioxidant supplementation with or without B-group vitamins after acute ischemic stroke: a randomized controlled trial
2006 · Antioxidant vitamins plus B-group vitamins · Acute ischemic stroke patients treated within 12 hours of symptom onset
400 mcg5 mg2 weeks24
Enhanced reduction of fasting total homocysteine levels with supraphysiological versus standard multivitamin dose folic acid supplementation in renal transplant recipients
1999 · group 1 · Chronic, stable renal transplant recipients; age and sex not stated
400 mcg2.4 mg12 weeks20
Enhanced reduction of fasting total homocysteine levels with supraphysiological versus standard multivitamin dose folic acid supplementation in renal transplant recipients
1999 · group 2 · Chronic, stable renal transplant recipients; age and sex not stated
400 mcg400 mcg12 weeks20
Hyperhomocysteinemia and endothelial function in young subjects: effects of vitamin supplementation
2002 · vitamin supplementation · Male volunteers aged 40 years or younger; nine matched pairs received vitamins, including hyperhomocysteinemic and normohomocysteinemic subjects
800 mcg600 mcg8 weeks18
[Treatment of hyperhomocysteinemia and endothelial dysfunction in renal-transplant recipients with vitamin B]
2005 · vitamin treatment (group A) · Stable hyperhomocysteinemic renal-transplant recipients
1 mg5 mg26 weeks18
Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial
2020 · DHA treatment arm · Cognitively unimpaired men and women aged 55 years and older with a first-degree family history of dementia
1 mg800 mcg26 weeks18
Nutritional status-dependent DNA methylation modifications on adipose tissue in systemic lupus erythematosus women following folic acid and vitamin B12 supplementation: a randomized double-blind placebo-controlled trial
2026 · excess-body-weight intervention group · Women aged 18–45 with inactive systemic lupus erythematosus and excess body weight (BMI ≥25 kg/m²)
2 mcg400 mcg12 weeks14
Nutritional status-dependent DNA methylation modifications on adipose tissue in systemic lupus erythematosus women following folic acid and vitamin B12 supplementation: a randomized double-blind placebo-controlled trial
2026 · normal-weight intervention group · Women aged 18–45 with inactive systemic lupus erythematosus and normal weight (BMI 18.5–24.9 kg/m²)
2 mcg400 mcg12 weeks11
Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients
2001 · Renal transplant recipients · Renal transplant recipients with hyperhomocysteinemia
400 mcg2.4 mg12 weeks10
Folic acid and vitamin B12 are more effective than vitamin B6 in lowering fasting plasma homocysteine concentration in patients with coronary artery disease
2004 · folic acid combined with vitamin B(12) · Patients with coronary artery disease and at least 70% stenosis of one major coronary artery
250 mcg5 mg12 weeks9
Treatment of hyperhomocysteinemia in renal transplant recipients. A randomized, placebo-controlled trial
1997 · folic acid plus vitamin B12 · Clinically stable renal transplant recipients
400 mcg5 mg—7
Treatment of hyperhomocysteinemia in renal transplant recipients. A randomized, placebo-controlled trial
1997 · vitamin B6, folic acid, and vitamin B12 · Clinically stable renal transplant recipients
400 mcg5 mg—7
Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients
2001 · Hemodialysis patients receiving folic acid · Hemodialysis patients with hyperhomocysteinemia and baseline total homocysteine comparable to the renal transplant recipients
1 mg15 mg12 weeks—
Oral vitamin B(12) and high-dose folic acid in hemodialysis patients with hyper-homocyst(e)inemia
2001 · 0 mg folic acid group · Adults with hyper-homocyst(e)inemia receiving hemodialysis for end-stage renal disease
1 mg1 mg4 weeks—
Vitamin supplementation can markedly reduce the homocysteine elevation induced by fenofibrate
2001 · fenofibrate plus vitamins · men with hyperlipidemia
50 mcg650 mcg6 weeks—
Total homocysteine lowering treatment among coronary artery disease patients in the era of folic acid-fortified cereal grain flour
2002 · Folic acid, riboflavin, and vitamin B12 without vitamin B6 · Adults with stable coronary artery disease; mean age 60.1 years; 29.8% women
400 mcg2.5 mg12 weeks—
Hyperhomocysteinaemia therapy in haemodialysis patients: folinic versus folic acid in combination with vitamin B6 and B12
2002 · Group 3 · Chronic haemodialysis patients; age and sex not specified
429 mcg6.43 mg26 weeks—
Effect of homocysteine reduction by B-vitamin supplementation on markers of clotting activation
2002 · high-dose B-vitamin supplements · Healthy volunteers with homocysteine >16 μmol/L or ≤16 μmol/L
400 mcg5 mg8 weeks—
Coronary endothelial function in hyperhomocysteinemia: improvement after treatment with folic acid and cobalamin in patients with coronary artery disease
2002 · folic acid/cobalamin treated group · Patients with coronary artery disease and hyperhomocysteinemia, plasma homocysteine ≥16 micromol/L; age and sex not reported
400 mcg5 mg26 weeks—
Reduction of plasma homocysteine and serum methylmalonate concentrations in apparently healthy elderly subjects after treatment with folic acid, vitamin B12 and vitamin B6: a randomised trial
2003 · B-vitamin treatment · Community-dwelling apparently healthy adults aged 70–93 years; median age 76 years
500 mcg800 mcg120 days—
Mineral water fortified with folic acid, vitamins B6, B12, D and calcium improves folate status and decreases plasma homocysteine concentration in men and women
2004 · Fortified mineral water · Free-living men and women without folate deficiency or elevated homocysteine
7.5 mcg563 mcg8 weeks—
Breakfast cereal fortified with folic acid, vitamin B-6, and vitamin B-12 increases vitamin concentrations and reduces homocysteine concentrations: a randomized trial
2004 · Fortified cereal group · Volunteers aged 50–85 years without the listed medical conditions who did not regularly use multiple or B-vitamin supplements or highly fortified breakfast cereal
4.8 mcg440 mcg12 weeks—
Changes in basal and postmethionine load concentrations of total homocysteine and cystathionine after B vitamin intervention
2004 · group B · Patients with suspected coronary artery disease; age and sex not stated
400 mcg5.8 mg90 days—
Insulin resistance and endothelial function are improved after folate and vitamin B12 therapy in patients with metabolic syndrome: relationship between homocysteine levels and hyperinsulinemia
2004 · group 2 · Patients with metabolic syndrome; age range and sex not reported
500 mcg5 mg30 days—
The effect of homocysteine reduction by B-vitamin supplementation on markers of endothelial dysfunction
2004 · B-vitamins · Healthy volunteers, including hyperhomocysteinemic and normohomocysteinemic participants
400 mcg5 mg8 weeks—
Efficacy of B vitamins in lowering homocysteine in older men: maximal effects for those with B12 deficiency and hyperhomocysteinemia
2006 · Vitamin group · Community-dwelling men aged 75 years or older
400 mcg2 mg2 years—
Effect of short-term folate and vitamin B supplementation on blood homocysteine level and carotid artery wall thickness in chronic hemodialysis patients
2006 · Treatment group · Chronic hemodialysis patients with hyperhomocysteinemia; age and sex not specified
1 mg15 mg26 weeks—
Effect of fortified spread on homocysteine concentration in apparently healthy volunteers
2007 · spread 1 · Apparently healthy adult volunteers; 50% male; age range not reported
2 mcg200 mcg6 weeks—
Effect of fortified spread on homocysteine concentration in apparently healthy volunteers
2007 · spread 2 · Apparently healthy adult volunteers; 50% male; age range not reported
2 mcg400 mcg6 weeks—
Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease
2007 · A: folic acid/vitamin B12/vitamin B6 · Adults aged 38–80 with suspected coronary artery disease
400 mcg800 mcg26 weeks—
Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease
2007 · B: folic acid/vitamin B12 · Adults aged 38–80 with suspected coronary artery disease
400 mcg800 mcg26 weeks—
Folic acid and vitamin B-12 supplementation does not favorably influence uracil incorporation and promoter methylation in rectal mucosa DNA of subjects with previous colorectal adenomas
2007 · folic acid plus vitamin B-12 · People with a history of colorectal adenoma and MTHFR CC or TT genotype
1.25 mg5 mg26 weeks—
Treatment of hyperhomocysteinemia and endothelial dysfunction in renal transplant recipients with B vitamins in the Chinese population
2008 · folate treatment · Chinese renal transplant recipients with hyperhomocysteinemia; age and sex not reported
1 mg5 mg26 weeks—
Effect of homocysteine-lowering therapy on arterial elasticity and metabolic parameters in metformin-treated diabetic patients
2008 · group 1 · Adults with diabetes treated with high-dose metformin
400 mcg1 mg120 days—
Serum biomarkers for atrophic gastritis and antibodies against Helicobacter pylori in the elderly: Implications for vitamin B12, folic acid and iron status and response to oral vitamin therapy
2008 · oral vitamin treatment · Community-dwelling adults, mean age 76 years
500 mcg800 mcg120 days—
The effects of vitamin supplementation and MTHFR (C677T) genotype on homocysteine-lowering and migraine disability
2009 · vitamin supplementation · patients diagnosed with migraine with aura; age and sex not reported
400 mcg2 mg26 weeks—
Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients
2009 · group II (folic acid and vitamin B12) · Hemodialysis patients; age and sex not reported
1 mg5 mg8 weeks—
Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients
2009 · group IV (folic acid and vitamin B12) · Hemodialysis patients; age and sex not reported
1 mg15 mg8 weeks—
Homocysteine-lowering vitamins do not lower plasma S-adenosylhomocysteine in older people with elevated homocysteine concentrations
2010 · vitamins group · Healthy adults aged 65 years or older with elevated homocysteine (>13 micromol/l)
500 mcg1 mg2 years—
Effect of physiological doses of oral vitamin B12 on plasma homocysteine: a randomized, placebo-controlled, double-blind trial in India
2010 · B2 F200 (2 μg vitamin B12 and 200 μg folic acid) · Children and adults from rural families in India; participants included children (mean age 9 years), mothers and fathers, with common vitamin B12 deficiency and elevated homocysteine
2 mcg200 mcg1 year—
Effect of physiological doses of oral vitamin B12 on plasma homocysteine: a randomized, placebo-controlled, double-blind trial in India
2010 · B10 F200 (10 μg vitamin B12 and 200 μg folic acid) · Children and adults from rural families in India; participants included children (mean age 9 years), mothers and fathers, with common vitamin B12 deficiency and elevated homocysteine
10 mcg200 mcg1 year—
Community-level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India
2010 · multiple micronutrients (treatment group) · Schoolchildren aged 6–10 years in Himalayan villages of India
1.35 mcg225 mcg240 days—
Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment
2013 · B-vitamin treatment · Elderly adults with mild cognitive impairment and increased dementia risk
500 mcg800 mcg2 years—
The association between progression of atherosclerosis and the methylated amino acids asymmetric dimethylarginine and trimethyllysine
2013 · Folic acid plus vitamin B12 plus vitamin B6 · Adults with suspected or established coronary artery disease who underwent coronary angiography; median age 60 years
400 mcg800 mcg316 days—
The association between progression of atherosclerosis and the methylated amino acids asymmetric dimethylarginine and trimethyllysine
2013 · Folic acid plus vitamin B12 · Adults with suspected or established coronary artery disease who underwent coronary angiography; median age 60 years
400 mcg800 mcg316 days—
Urinary excretion of homocysteine thiolactone and the risk of acute myocardial infarction in coronary artery disease patients: the WENBIT trial
2019 · folic acid + vitamin B12 + vitamin B6 · Adults with suspected coronary artery disease who underwent coronary angiography; mean age about 61 years, 69.8% male
400 mcg800 mcg165 weeks—
Urinary excretion of homocysteine thiolactone and the risk of acute myocardial infarction in coronary artery disease patients: the WENBIT trial
2019 · folic acid + vitamin B12 · Adults with suspected coronary artery disease who underwent coronary angiography; mean age about 61 years, 69.8% male
400 mcg800 mcg165 weeks—
Impact of daily-supervised administration of a package of iron and folic acid and vitamin B(12) on hemoglobin levels among adolescent girls (12-19 years): a cluster randomized control trial
2021 · Experimental group-IFA with vitamin B12 · Adolescent girls aged 12–19 years with mild or moderate anemia
1 mg500 mcg90 days—
Vitamin requirements for the treatment of hyperhomocysteinemia in humans
1994 · combination of folic acid, vitamin B-12 and vitamin B-6 · men with hyperhomocysteinemia
400 mcg650 mcg6 weeks—
Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia
1993 · daily vitamin supplement · Apparently healthy men with moderate hyperhomocysteinemia
400 mcg1 mg6 weeks—
Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers
1998 · high-dose multivitamin supplements · Patients with a history of recurrent venous thrombosis and hyperhomocysteinemic healthy volunteers
400 mcg5 mg——
Effects of folic acid and combinations of folic acid and vitamin B-12 on plasma homocysteine concentrations in healthy, young women
1998 · 400 microg folic acid + 6 microg vitamin B-12 · Female volunteers of childbearing age
6 mcg400 mcg4 weeks—
Effects of folic acid and combinations of folic acid and vitamin B-12 on plasma homocysteine concentrations in healthy, young women
1998 · 400 microg folic acid + 400 microg vitamin B-12 · Female volunteers of childbearing age
400 mcg400 mcg4 weeks—
A novel nutritional supplement to reduce plasma homocysteine in nonpregnant women: A randomised controlled trial in The Gambia
2019 · UNIMMAP tablet · Nonpregnant, non-lactating healthy women aged 18–45 years in West Kiang, The Gambia; women of reproductive age with common micronutrient deficiencies in the population
2.6 mcg400 mcg12 weeks105
A novel nutritional supplement to reduce plasma homocysteine in nonpregnant women: A randomised controlled trial in The Gambia
2019 · drink powder · Nonpregnant, non-lactating healthy women aged 18–45 years in West Kiang, The Gambia; women of reproductive age with common micronutrient deficiencies in the population
5.2 mcg800 mcg12 weeks93
Nutraceutical approaches to homocysteine lowering in hypertensive subjects at low cardiovascular risk: a multicenter, randomized clinical trial
2016 · Normocis 400® group · Adults with stage 1 essential hypertension and hyper-homocysteinemia (HCys ≥15 μmol/L), without a history of cardiovascular or cerebrovascular disease; mean age 62.8 years, 63.5% male
5 mcg400 mcg60 days52
Randomized placebo-controlled trial assessing a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on plasma asymmetric dimethylarginine concentration in mild to moderate CKD
2009 · Treatment group · Adults with stage 2 to 4 chronic kidney disease and creatinine clearance of 15 to 70 mL/min/1.73 m²
1 mg5 mg2 years47
Effects of low-dose B vitamins plus betaine supplementation on lowering homocysteine concentrations among Chinese adults with hyperhomocysteinemia: a randomized, double-blind, controlled preliminary clinical trial
2023 · supplement group · Chinese adults aged 18–65 with hyperhomocysteinemia (blood homocysteine 15–100 μmol/L)
6.4 mcg400 mcg12 weeks44
Plasma trimethylamine-N-oxide following supplementation with vitamin D or D plus B vitamins
2017 · vitamin D + B arm · Participants; age, sex, and health condition not specified
500 mcg500 mcg1 year25
High dose-B-vitamin treatment of hyperhomocysteinemia in dialysis patients
1996 · Supraphysiologic-dose B-vitamin supplementation · Hyperhomocysteinemic dialysis patients
1 mg15 mg8 weeks15
Oral vitamin B(12) and high-dose folic acid in hemodialysis patients with hyper-homocyst(e)inemia
2001 · 5 mg folic acid group · Adults with hyper-homocyst(e)inemia receiving hemodialysis for end-stage renal disease
1 mg6 mg4 weeks—
Oral vitamin B(12) and high-dose folic acid in hemodialysis patients with hyper-homocyst(e)inemia
2001 · 20 mg folic acid group · Adults with hyper-homocyst(e)inemia receiving hemodialysis for end-stage renal disease
1 mg21 mg4 weeks—
Prophylactic iron supplementation in pregnant women in Norway
2001 · 15 mg iron daily · Non-anaemic pregnant women, allocated at about 10 weeks of pregnancy
3 mcg100 mcg——
Total homocysteine lowering treatment among coronary artery disease patients in the era of folic acid-fortified cereal grain flour
2002 · Folic acid, riboflavin, and vitamin B12 with vitamin B6 · Adults with stable coronary artery disease; mean age 60.1 years; 29.8% women
400 mcg2.5 mg12 weeks—
Folate therapy and in-stent restenosis after coronary stenting
2004 · folate group · Patients who had undergone successful coronary stenting
60 mcg1.2 mg26 weeks—
Changes in basal and postmethionine load concentrations of total homocysteine and cystathionine after B vitamin intervention
2004 · group A · Patients with suspected coronary artery disease; age and sex not stated
400 mcg5.8 mg90 days—
Homocysteine in chronic kidney disease: Effect of low protein diet and repletion with B vitamins
2005 · All subjects · Adults with chronic kidney disease in MDRD Study A (GFR 25–55 mL/min/1.73 m²) or Study B (GFR 13–24 mL/min/1.73 m²)
6 mcg1 mg1 year—
No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease
2006 · B-vitamin group · Patients with symptomatic peripheral arterial occlusive disease and elevated homocysteine levels
50 mcg5 mg6 weeks—
One year B and D vitamins supplementation improves metabolic bone markers
2013 · group A · Healthy adults older than 54 years
500 mcg500 mcg1 year—
Co-administration of methyl donors along with guanidinoacetic acid reduces the incidence of hyperhomocysteinaemia compared with guanidinoacetic acid administration alone
2013 · GAA with methyl donors group · Healthy male and female volunteers
5 mcg600 mcg8 weeks—
Effects of mixed dietary supplements on total plasma homocysteine concentrations (tHcy): a randomized, double-blind, placebo-controlled trial
2012 · supplement group · hospitalized, acutely ill older patients recovering from acute illness; sex and age range not stated
1.5 mcg200 mcg6 weeks—
One-carbon metabolites and telomere length in a prospective and randomized study of B- and/or D-vitamin supplementation
2017 · group A · Adults older than 54 years; no specific condition stated
500 mcg500 mcg1 year—
Multimicronutrient and omega-3 fatty acid supplementation reduces low-grade inflammation in older participants: An exploratory study
2025 · multimicronutrient and n-3 PUFA supplementation · Healthy, physically active older adults; mean age 75.6 ± 3.9 years; sex not specified
100 mcg400 mcg12 weeks—
Vitamin B12 Supplementation in Addition to Folic Acid and Iron Improves Hematological and Biochemical Markers in Pregnancy: A Randomized Controlled Trial
2020 · intervention group · Healthy, nonanemic pregnant women; age and sex details beyond pregnancy not reported
5 mcg5 mg100 days—
Betaine as a determinant of postmethionine load total plasma homocysteine before and after B-vitamin supplementation
2004 · folic acid, vitamin B12, and vitamin B6 group · Patients undergoing coronary angiography
400 mcg800 mcg1 year—
Betaine as a determinant of postmethionine load total plasma homocysteine before and after B-vitamin supplementation
2004 · folic acid and vitamin B12 group · Patients undergoing coronary angiography
400 mcg800 mcg1 year—